Effect of aminoglycoside on mechanical properties of zwitterionic phospholipid vesicles

Jin-Won Park1

  • 1Department of Chemical Engineering, College of Engineering, Seoul National University of Science and Technology, Seoul, South Korea. jwpark@seoultech.ac.kr

Insights

Aminoglycosides (streptomycins) did not alter the nanomechanical properties of dipalmitoylphosphatidylcholine (DPPC) vesicles. This suggests that these compounds do not disrupt the lipid packing within the vesicle bilayers.

Area of Science:

  • Biophysics
  • Materials Science
  • Nanotechnology

Background:

  • Dipalmitoylphosphatidylcholine (DPPC) forms the primary structure of biological membranes.
  • Aminoglycosides (AGs) are a class of antibiotics with potential membrane interactions.
  • Understanding drug-lipid interactions is crucial for drug delivery and membrane biophysics.

Purpose of the Study:

  • To investigate the impact of streptomycin incorporation on the nanomechanical properties of DPPC vesicles.
  • To determine if streptomycin affects the Young's modulus and bending modulus of lipid bilayers.
  • To assess the potential for streptomycin to disrupt DPPC packing at the nanoscale.

Main Methods:

  • Preparation of pure DPPC vesicles using extrusion.
  • Adsorption of vesicles onto a mica surface for Atomic Force Microscopy (AFM) analysis.
  • Force measurements using AFM to probe vesicle nanomechanics.
  • Application of Hertzian model to analyze force-distance curves and extract mechanical properties.

Main Results:

  • Atomic Force Microscopy revealed two breakthrough events per vesicle, corresponding to bilayer penetration.
  • Young's modulus and bending modulus were successfully estimated using the Hertzian model.
  • No significant variation in Young's modulus or bending modulus was observed with streptomycin incorporation.
  • Mechanical properties remained consistent up to a 1:1 AG/DPPC vesicle system.

Conclusions:

  • Streptomycin does not appear to alter the nanomechanical properties of DPPC vesicles.
  • The observed data suggest that aminoglycosides do not disrupt the packing of DPPC lipids.
  • Further studies may explore the implications of these findings for drug-membrane interactions.